Literature DB >> 8321836

Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets.

B Abrahamsson1, M Alpsten, M Hugosson, U E Jonsson, M Sundgren, A Svenheden, J Tölli.   

Abstract

The gastrointestinal transit and tablet erosion of felodipine extended release (ER) tablets 10 mg were studied by gamma scintigraphy in eight healthy young males after administration under fasting and nonfasting conditions. Plasma concentrations of felodipine were also measured. Gastric emptying after administration together with food (mean, 3.2 hr) was slower in all subjects compared to emptying under fasting conditions (mean, 0.6 hr). The mean small intestinal transit times for the two study conditions did not differ significantly (5.1 and 4.7 hr, respectively). Tablets did not leave the colon in any subject within 14 hr after administration. Felodipine was shown to be absorbed in the colon, although the major part of the dose was absorbed in the small intestine. The absorption rate of felodipine was related to erosion of the hydrophilic matrix tablet. Tablet erosion and hence drug absorption were slower in the more distal parts of the gastrointestinal tract. Administration together with food did not significantly affect tablet erosion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321836     DOI: 10.1023/a:1018959732744

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets.

Authors:  E Blychert; K Wingstrand; B Edgar; K Lidman
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

2.  Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy.

Authors:  S S Davis; N Washington; G D Parr; A H Short; V A John; P Lloyd; S M Walker
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

3.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

4.  Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report.

Authors:  V A John; P A Shotton; J Moppert; W Theobald
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of felodipine. A summary.

Authors:  B Edgar; P Lundborg; C G Regårdh
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  Plasma concentration-effect relationships of intravenous and extended-release oral felodipine in hypertensive patients.

Authors:  E Blychert; T Hedner; C Dahlöf; D Elmfeldt
Journal:  J Cardiovasc Pharmacol       Date:  1990-03       Impact factor: 3.105

7.  Determination of felodipine in plasma by capillary gas chromatography with electron capture detection.

Authors:  M Ahnoff
Journal:  J Pharm Biomed Anal       Date:  1984       Impact factor: 3.935

8.  Pharmacokinetic and pharmacodynamic studies of felodipine in healthy subjects after various single, oral and intravenous doses.

Authors:  B Edgar; C G Regårdh; P Lundborg; S Romare; G Nyberg; O Rönn
Journal:  Biopharm Drug Dispos       Date:  1987 May-Jun       Impact factor: 1.627

9.  Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR).

Authors:  I R Wilding; J G Hardy; S S Davis; C D Melia; D F Evans; A H Short; R A Sparrow; K C Yeh
Journal:  Clin Neuropharmacol       Date:  1991-08       Impact factor: 1.592

10.  Vascular selectivity of felodipine.

Authors:  B Ljung
Journal:  Drugs       Date:  1985       Impact factor: 9.546

  10 in total
  12 in total

1.  Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

Authors:  H Takanaga; A Ohnishi; H Matsuo; H Murakami; H Sata; K Kuroda; A Urae; S Higuchi; Y Sawada
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

2.  A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach.

Authors:  Bertil Abrahamsson; Anupam Pal; Marie Sjöberg; Maria Carlsson; Emma Laurell; James G Brasseur
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

3.  Assessment of blood level with controlled-release dosage forms: effect of the rate constant of elimination of the drug.

Authors:  A Aïnaoui; J M Vergnaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

Review 4.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

5.  Design and evaluation of matrix base with sigmoidal release profile for colon-specific delivery using a combination of Eudragit and non-ionic cellulose ether polymers.

Authors:  Laila Fatima Ali Asghar; Sajeev Chandran
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

6.  Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.

Authors:  P H Marathe; Y Wen; J Norton; D S Greene; R H Barbhaiya; I R Wilding
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

Review 7.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

8.  Effect of Excessive Serotonin on Pharmacokinetics of Cephalexin after Oral Administration: Studies with Serotonin-Excessive Model Rats.

Authors:  Shun Nakashima; Takeharu Iwamoto; Masashi Takanashi; Ken-Ichi Ogawara; Masato Maruyama; Kazutaka Higaki
Journal:  Pharm Res       Date:  2022-07-08       Impact factor: 4.580

Review 9.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

10.  Oral solid controlled release dosage forms: role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans.

Authors:  M Shameem; N Katori; N Aoyagi; S Kojima
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.